- Personalised chemotherapy based on tumour marker decline in poor prog…
Number of the records: 1  

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial

  1. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial / Mardiak J., Reckova M. ... [et al.]. Onkológia Roč. 10, č. 1 (2015), s. 60
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all